Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Gilmartin Capital LLC is a healthcare investment firm founded in 2021 by David Lewis, a former Managing Director at Morgan Stanley. The firm is headquartered in San Francisco, California, and focuses on supporting entrepreneurs and companies developing innovative solutions in the healthcare sector. Gilmartin Capital emphasizes domain expertise in medical technology, aiming to drive advancements in medical devices, life science tools, diagnostics, and digital health technologies.
Since its inception, Gilmartin Capital has launched its first fund, Gilmartin Capital Fund I, L.P., which was meaningfully oversubscribed at its first close in November 2021. The firm primarily attracts limited partners who are executives, operators, and scientific thought leaders from the healthcare industry. Gilmartin Capital's portfolio includes notable companies such as Shoulder Innovations and Kestra Medical Technologies, reflecting its commitment to investing in transformative healthcare solutions.
Gilmartin Capital invests in sectors including Medical Devices, Life Science Tools, Diagnostics, and Digital Health. The firm targets opportunities that are beyond proof of concept and poised for significant development and growth. Their investment strategy emphasizes domain expertise in strategy, market assessment, and capital markets advisory. Gilmartin Capital seeks platforms that address large or underserved diseases and technologies that enhance scientific discovery while optimizing the cost and delivery of care.
The firm focuses on investment stages ranging from seed to growth equity, ensuring that they engage with companies ready for expansion. Gilmartin Capital's approach combines deep industry knowledge with a commitment to supporting innovative healthcare solutions that can make a meaningful impact in the medical technology space.
Gilmartin Capital has supported various medical technology innovators, including:
These portfolio companies exemplify Gilmartin Capital's focus on investing in disruptive healthcare solutions that target significant market needs and enhance patient care.
David Lewis - Managing Partner. David has over 15 years of experience as the Managing Director and Head of Medical Technology Equity Research at Morgan Stanley. He brings extensive knowledge of the healthcare sector and a strong background in equity research.
Jonathan Demchick - Co-Founder & Principal. Jonathan has a background in healthcare investment and has played a key role in shaping Gilmartin Capital's investment strategy.
To pitch Gilmartin Capital, founders should visit their website at gilmartincap.com. It is recommended to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. While specific response time expectations are not disclosed, founders should anticipate a thorough review process given the firm's focus on healthcare investments.
In March 2023, Gilmartin Capital participated in a $40M Series E funding round for Shoulder Innovations, a company specializing in orthopedic medical devices. Additionally, the firm has engaged in venture rounds for Kestra Medical Technologies, known for its wearable medical devices and digital healthcare solutions. These activities highlight Gilmartin Capital's ongoing commitment to investing in innovative healthcare solutions.
What are Gilmartin Capital's investment criteria?
Gilmartin Capital invests in medical devices, life science tools, diagnostics, and digital health sectors. They focus on platforms addressing large or underserved diseases and technologies that advance scientific discovery while optimizing care delivery. Investments are typically in companies that are beyond proof of concept and ready for expansion.
How can I pitch to Gilmartin Capital?
Founders can pitch to Gilmartin Capital through their website at gilmartincap.com. It is advisable to include a detailed deck that outlines the business model, market opportunity, and team background.
What makes Gilmartin Capital different from other investors?
Gilmartin Capital's focus on disruptive healthcare solutions and their expertise in market assessment and capital markets advisory set them apart. Their team has extensive experience in the healthcare sector, which they leverage to provide strategic guidance to portfolio companies.
What is the geographic scope of Gilmartin Capital's investments?
The firm primarily invests in companies based in the United States, focusing on the healthcare sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, Gilmartin Capital targets investment stages from seed to growth equity, indicating a range that can accommodate various funding needs.
What kind of post-investment involvement does Gilmartin Capital have?
Gilmartin Capital adds value through strategic guidance, market assessment, and capital markets advisory, leveraging their team's extensive experience in the healthcare sector to support portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.